GLP-1 receptor comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2025-08-31. Numbers and descriptions here follow the published literature rather than marketing material.
Reported outcomes in large trials include dose-dependent weight reduction and improvements in glycemic markers over periods ranging from several months to more than a year. Whether the compound alters long-term cardiovascular or renal outcomes is being examined in dedicated outcome studies, so those questions remain open. Labeling describes gastrointestinal effects such as nausea and diarrhea, which tend to appear during dose escalation. Discontinuation rates and the durability of effects after treatment stops vary across study populations and are still debated.
Tirzepatide is a synthetic peptide developed as a dual agonist at the glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptors. Its structure is built on a GIP-derived backbone with non-natural amino acid substitutions and a fatty diacid side chain that promotes albumin binding and slows clearance. That modification supports once-weekly subcutaneous dosing. Registrational trial programs reported reductions in body weight and glycated hemoglobin alongside the drug's glycemic effects.
Both receptors are class B G protein-coupled receptors that signal largely through Gs-mediated cyclic AMP production. Activation within pancreatic islets increases glucose-dependent insulin secretion and suppresses glucagon release when glucose is elevated. Outside the pancreas, signaling in the central nervous system and gut appears to influence appetite and gastric emptying. The relative contribution of each receptor to observed clinical effects remains under investigation, and the two pathways are not simply additive in practice.
Like most synthetic peptides of this size, the material is commonly supplied as a lyophilised powder that appears white to off-white. It dissolves in aqueous buffers and in mixtures of water with a small proportion of organic solvent, though the fatty acid portion reduces solubility in pure water relative to short peptides. Hygroscopic behaviour is reported for many peptide powders, so weighing is usually performed quickly and under controlled humidity. Working solutions are typically prepared fresh and kept cold.
Long-term storage of lyophilised peptide powder is generally at minus twenty degrees Celsius or colder, with desiccant and protection from light. Short-term storage at two to eight degrees Celsius is common during active use. In solution, stability depends strongly on pH, concentration, and the presence of preservatives, and hydrolysis or aggregation can develop over weeks. Published stability data specific to this molecule are limited, so recommended conditions for research material are usually extrapolated from general peptide handling practice rather than from a dedicated study.
Bulk peptide material is normally characterised by reversed-phase high-performance liquid chromatography, which separates the target sequence from truncation products and other closely related impurities. Ultraviolet detection near 214 nanometres is common because the peptide backbone absorbs in that region. Mass spectrometry, usually electrospray ionisation coupled to a mass analyser, is used to confirm the molecular mass. Because the molecule carries a lipophilic side chain, gradient methods often need a relatively high organic modifier fraction to elute it within a practical retention window.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic 39-residue peptide | GIP-derived backbone with non-natural residues |
| Molar mass | Approximately 4.8 kDa | Peptide chain plus linker and lipid modifications |
| Appearance | White to off-white powder | Typical of lyophilized research material |
| Solubility | Soluble in water and aqueous buffer | Practically insoluble in nonpolar solvents |
| Storage temperature | Typically −20 °C for dry powder | Solutions usually held at 2–8 °C short term |
Structural work on the molecule centers on a C20 fatty diacid moiety attached through a linker to the peptide backbone. This side chain promotes reversible binding to serum albumin, which slows renal clearance and supports a prolonged action profile. The peptide backbone incorporates aminoisobutyric acid substitutions that limit recognition by digestive enzymes. Together these modifications produce a molecule that is stable enough for subcutaneous delivery but still dependent on careful manufacturing control. Analytical characterization of the active pharmaceutical ingredient typically follows the conventions used for other synthetic peptides.
Tirzepatide is a synthetic peptide composed of 39 amino acids. It acts as a dual agonist at two incretin receptors, the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor. The molecule was designed by modifying the native sequence of glucose-dependent insulinotropic polypeptide to improve metabolic stability and extend its circulation time. Its structure includes several non-natural amino acid residues and a fatty acid side chain. These features distinguish it from earlier single-receptor incretin analogs studied in the same period.
Verification of research-grade material involves checking purity, sequence and counter-ion content against a certificate of analysis. Reported purity figures usually reflect chromatographic area percentage and do not by themselves establish biological activity. Independent laboratories may repeat mass confirmation and peptide mapping to detect substitutions or truncations. Open questions concern how residual solvents, trace metals and subtle conformational variants affect measured behavior, and how consistently different suppliers define their specifications. Documentation of analytical methods matters as much as the headline purity number when results are compared across studies.
Routine characterization relies on reversed-phase high-performance liquid chromatography, often coupled to mass spectrometry, to confirm identity and estimate purity. Peptide mapping after enzymatic digestion verifies the amino acid sequence and locates appended groups such as the fatty acid chain. Size-exclusion chromatography detects aggregates and fragments, while ion-exchange chromatography resolves charge variants. Circular dichroism and nuclear magnetic resonance supply secondary and higher-order structural information in research settings. No single technique covers every attribute, so laboratories combine orthogonal methods and compare outcomes against a reference standard where one exists.
After subcutaneous injection, absorption is gradual, and peak plasma levels are generally reached within one to three days. Albumin binding extends the apparent half-life to roughly five days, which supports a weekly administration schedule. Metabolism proceeds mainly through proteolytic cleavage of the peptide backbone and beta-oxidation of the fatty acid chain, rather than through cytochrome P450 pathways. Eliminated fragments are largely recycled through general protein turnover, and excretion of intact drug in urine is minimal. These properties distinguish the molecule from short-acting incretin mimetics.
Tirzepatide is a synthetic peptide of 39 amino acids engineered from the native glucose-dependent insulinotropic polypeptide sequence. Its structure incorporates several non-natural residues and a C-terminal segment derived from glucagon-like peptide-1, together with a C20 fatty diacid moiety attached through a linker. The lipophilic side chain promotes binding to serum albumin, which slows renal clearance after administration. The compound is classified as a dual incretin receptor agonist and is supplied as a lyophilized powder for reconstitution or as a preformulated solution, depending on the presentation.
The peptide activates two G protein-coupled receptors, GIPR and GLP-1R. Binding triggers adenylyl cyclase activity and raises intracellular cyclic AMP in pancreatic beta cells, which potentiates insulin release when glucose is elevated. Signaling in the central nervous system is associated with reduced appetite and lower energy intake, while effects on gastric emptying and glucagon secretion are also reported. Because activity at both receptors is retained, the pharmacological profile is often described as incretin-based rather than selective for a single receptor.
Development began in the 2010s, when researchers modified a GIP-based scaffold to add GLP-1 activity and then attached the fatty diacid to lengthen its half-life. Clinical evaluation proceeded through large phase 3 programmes in type 2 diabetes and in obesity, and regulators in the United States cleared the compound for type 2 diabetes in 2022 and for chronic weight management in 2023. Several cardiovascular and metabolic outcome studies are still reporting, so the picture of long-term benefit and risk is incomplete. Approvals in other regions followed on different timelines.
Tirzepatide is a synthetic peptide of 39 amino acids that carries a C20 fatty diacid side chain attached through a linker. Its molecular formula is C225H348N48O68, and its molecular weight is about 4813 daltons. The compound belongs to the incretin mimetic class and is administered by subcutaneous injection. The fatty acid chain promotes binding to serum albumin, which slows renal clearance and extends the circulation time of the molecule. It was identified during screening of sequences derived from glucose-dependent insulinotropic polypeptide.
Tirzepatide activates both the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor, making it a dual agonist rather than a selective agent. Engagement of the GLP-1 receptor is linked to glucose-dependent insulin release, slower gastric emptying, and reduced appetite signalling. The relative contribution of the GIP arm remains an active research question; proposed roles include improved insulin sensitivity and altered adipose tissue handling. Receptor occupancy studies suggest the molecule interacts with both targets at circulating concentrations achieved during therapy.
In 1986, Australians Kevin Barlow and Brian Chambers became the first Westerners executed under Malaysia's mandatory death penalty for drug trafficking, despite last-minute clemency appeals from Australia and the United Kingdom. Mahathir defended the decision, emphasizing that Malaysia's strict anti-drug laws applied equally to all, regardless of nationality or background. In Mahathir's early years as prime minister, Malaysia experienced a resurgence of Islam and conservatism among Malays. PAS, which had joined UMNO in government in the 1970s, responded to the resurgence by taking an increasingly strident Islamist stand under the leadership of Yusof Rawa. Mahathir tried to appeal to religious voters by establishing Islamic institutions such as the International Islamic University of Malaysia which could promote Islamic education under government oversight. He managed to draw Anwar Ibrahim, the leader of the Malaysian Islamic Youth Movement (ABIM), into the ranks of UMNO. In some cases, Mahathir's government employed repression against more extreme exponents of Islamism. Ibrahim Libya, a popular Islamist leader, was killed in a police shoot-out in 1985. Al-Arqam, a religious sect, was banned, and its leader, Ashaari Mohammad, was arrested under the Internal Security Act. Mahathir comprehensively defeated PAS at the polls in 1986, winning 83 seats of the 84 seats it contested, leaving PAS with just one Member of Parliament (MP).
=== History === The family Liliaceae was described by Michel Adanson in 1763 and formally named by Antoine Laurent de Jussieu in 1789. Jussieu defined this grouping as having a calyx of six equal colored parts, six stamens, a superior ovary, single style, and a trilocular (three-chambered) capsule. By 1845, John Lindley, the first English systematist, unhappily acknowledged the great diversity in the circumscription of the family, and that it had expanded vastly, with many subdivisions. As he saw it, the Liliaceae were already paraphyletic ("catch-all"), being all Liliales not included in the other families, but hoped that the future would reveal some characteristic that would group them better. He recognized 133 genera and 1200 species. By the time of the next major British classification – that of Bentham and Hooker in 1883 (published in Latin) – several of Lindley's other families had already been absorbed into the Liliaceae. Over time the family became increasingly broad and somewhat arbitrarily defined as all species of plants with six tepals and a superior ovary, eventually coming to encompass about 300 genera and 4,500 species within the order Liliales under the Cronquist system (1981). Cronquist merged the Liliaceae with the Amaryllidaceae, making this one of the largest monocotyledon families. Many other botanists echoed Lindley's earlier concerns about the phylogeny of the Liliaceae, but various schemes to divide the family gained little traction.
=== High Point Media === After Phillips sold his majority interest in EAS, he concentrated on his writing and on promotion of his books through his publishing company, High Point Media, as well as Value Creation, a branch of EAS. Body for Life hit bookstores in 1999, and by 2003 it had sold 3.5 million copies in 24 languages. The book topped the charts in 11 different countries-including the United States, England, Japan, Australia, Greece and Finland. In 2004 USA Today named it among the Top 15 bestselling books of the past decade. In November 2003, Eating for Life: Your Guide to Great Health, Fat Loss and Increased Energy! was released. In the book Phillips offers his plan "to help inspire and guide even more people to improve their health and lift their quality of life to new heights." In February 2006, Phillips announced his "Great American Transformation Experience" (GATE) with a goal to transform America's fitness from world's worst to first within 10 years. On June 21, 2010, Phillips' latest book, Transformation: The Mindset You Need. The Body You Want. The Life You Deserve was released. A companion website, Transformation.com, that walks individuals through the transformation process was also updated. The site features a community dedicated to supporting its members' personal goals. On July 10, 2010, the book made the New York Times Best Seller list.
1993/2957) A10 Trunk Road (Wadesmill, High Cross and Colliers End Bypass and Slip Road) Order 1993 (S.I. 1993/2963) A10 Trunk Road (North of Ware to South of Puckeridge) (Detrunking) Order 1993 (S.I. 1993/2964) Education (School Inspection) (Wales) (No. 2) (Amendment) Regulations 1993 (S.I. 1993/2968) Scottish College of Textiles (Scotland) Order of Council 1993 (S.I. 1993/2969) Civil Aviation (Route Charges for Navigation Services) (Amendment) Regulations 1993 (S.I. 1993/2970) Hereford and Worcester and West Midlands (County Boundaries) Order 1993 (S.I. 1993/2971) National Health Service (Service Committees and Tribunal) Amendment Regulations 1993 (S.I. 1993/2972) Education (School Inspection) (No. 2) (Amendment) Regulations 1993 (S.I. 1993/2973) Port of Bristol Harbour Revision Order 1993 (S.I. 1993/2974) Civil Aviation (Joint Financing) (Fifth Amendment) Regulations 1993 (S.I. 1993/2975) Gipsy Encampments (East Yorkshire Borough of Beverley) Order 1993 (S.I. 1993/2980)
Sources: en.wikipedia.org
=== Monoamine oxidase inhibitors === It is unclear whether mescaline is metabolized by monoamine oxidase (MAO) enzymes or whether monoamine oxidase inhibitors (MAOIs) might increase the effects of mescaline. No clinical studies of mescaline in combination with MAOIs are known to have been published. However, there are preliminary reports that harmala alkaloids, which are reversible inhibitors of monoamine oxidase A (RIMAs), may potentiate the effects of mescaline in humans, and the combination of mescaline or mescaline-containing cacti with harmala alkaloids has been referred to as "peyohuasca". In accordance with these findings, the harmala alkaloid and RIMA harmine has been reported to augment the effects of mescaline in animals. On the other hand, Daniel Trachsel has stated that mescaline is not metabolized by MAO, instead being metabolized by semicarbazide-sensitive amine oxidase (SSAO), and hence that MAOIs that do not also inhibit SSAO should have no effect on the metabolism of mescaline. Accordingly, the MAOI iproniazid did not potentiate the behavioral effects of mescaline in rats.
=== Priori Development and the ERIAD Controversy === John Fenn's development of electrospray ionization was preceded by the ERIAD method, a direct analogue created by Lidija Gall's group in the Soviet Union. Gall's team recorded mass spectra of peptides and proteins as early as 1981. During a 1983 visit to the Soviet Union, Fenn visited Lidija Gall's laboratory and engaged in "fruitful discussions" regarding her ERIAD method, which he described as "very promising". Although Gall published her findings in April 1984, which was five months before Fenn's first paper on the subject, her work remained largely unknown internationally for decades due to the "Iron Curtain". Despite this direct exposure to the technology and his comment that he would "try it in his lab," Fenn's subsequent 1984 publication did not cite Gall's earlier pioneering work. Gall's pioneering contributions were later recognized by the Nobel Committee in 2002 and through her receipt of the Thomson Medal in 2022.
Jon Wiederhorn of Rolling Stone called the album "liberating and enlightening, the songs achieve a startling, staggering and palpable impact." The band released the home video The Nona Tapes On December 12, a mockumentary featuring interviews with the band members conducted by journalist Nona Weisbaum (played by Jerry Cantrell), and the music video for "Grind". The band opted not to tour in support of Alice in Chains, adding to the rumors of drug abuse. The song "Got Me Wrong" unexpectedly charted three years after its release on the Sap EP. The song was re-released as a single on the soundtrack for the film Clerks in 1994, reaching number seven on the Mainstream Rock Tracks chart. Alice in Chains resurfaced on April 10, 1996, to perform for MTV Unplugged, a program featuring all-acoustic set lists. The performance featured some of the band's highest-charting singles, including "Rooster", "Down in a Hole", "Heaven Beside You", "No Excuses" and "Would?", and introduced a new song, "Killer Is Me", with Cantrell on lead vocals. The show marked Alice in Chains' only appearance as a five-piece band, adding second guitarist Scott Olson. A live album of the performance was released in July 1996, which debuted at number three on the Billboard 200, and was accompanied by a home video release, both of which received platinum certification by the RIAA. The band also appeared on The Late Show with David Letterman on May 10, 1996, performing the songs "Again" and "We Die Young".
The Bundeswehr uses the Einpersonenpackung to provide two substantial meals to each soldier. The standard practice is to provide one hot cooked meal for the other meal whenever possible. A heater or oven is not included since an Esbit cooker is part of each soldier's personal equipment. Enough food items are contained within the Einpersonenpackung to sustain the soldier for 24 hours. Currently there are three menus; each includes two meals out of a selection of 19 meals, with several heavy-duty foil trays containing items such as lentils with sausages, Yugoslav Sausage, Goulash, beef burgers in tomato sauce, Italian pasta, or Tofu stir-fry. There are also three smaller foil "cans" of bread spreads such as cheese spread, liver-sausage, dried-meat sausage, or cheese spread with green peppers. The meal box also includes: thinly sliced rye bread (170 g), hard crackers (1100 kcal), a foil can of fruit salad, instant cream of wheat, instant fruit juice powder, instant coffee, instant tea, powdered cream, a chocolate bar, sugar, salt, gum, jam, water purifying tablets, two plastic bags, matches, paper towels, and a user guide. The Einpersonenpackung ration is supplied in two types, rations 1 to 5 are packaged in a grey cardboard box with the meals packaged in sealed heavy duty foil trays which may be heated by immersing in hot water. The trays are opened using a knife or other sharp implement. Rations 6 to 19 are packaged in a resealable carry pouch, which are either NATO Olive coloured, desert brown or transparent. The meals are packed in retort pouches.
=== Other types === Various types are distinguished by the domain of life to which they belong. Physical well-being concerns the domain of the body, including the capacity to engage in physical activity and the absence of illness and bodily pain. It includes general health considerations and the ability to perform one's social role without being hindered by physical limitations. Psychological well-being, also called mental health, is a state of mind characterized by internal balance. It involves the absence or successful management of disorders and disturbances, together with the abilities to cope with challenging situations, maintain positive relationships, and cultivate personal growth. It is closely linked to intellectual, spiritual, and emotional well-being. Intellectual well-being encompasses well-functioning cognitive abilities and traits, such as critical thinking, problem-solving, and curiosity. Spiritual well-being is a state in which people find purpose in life and have inner peace, self-confidence, and a sense of identity. Emotional well-being involves the capacities to comprehend, articulate, and regulate emotions, together with an overall positive mood. Hedonic well-being refers to a life rich in pleasurable experiences and devoid of suffering. Eudaimonic well-being is a form of personal fulfillment in which an individual flourishes by striving for excellence and actualizing their innate potential.
Sources: en.wikipedia.org
Otherwise: Roast the potatoes like chestnuts in the ashes, peel and cut into slices. Sprinkle with chopped mint, pour boiled raisins, vinegar and sprinkle with pepper. (French: Autrement. Mettez roſtir la tartoufle dedans le cendres chaudes comme on cuit les caſtaignes, puis la faut peler & coupper par trãches, mettez ſus mente haſchee, des carentines boullies par deſſus, & vinaigre, vn peu de poiure, & ſeruez ainſi.)
=== Recreational drug use === Subcutaneous injection may also be used by people to (self-) administer recreational drugs. This can be referred to as skin popping. In some cases, the administration of illicit drugs in this way is associated with unsafe practices leading to infections and other adverse effects. In rare cases, this results in serious side effects such as AA amyloidosis. Recreational drugs reported to be administered subcutaneously have included cocaine, mephedrone, and amphetamine derivatives such as PMMA.
Azoospermia factor (AZF) is one of several proteins or their genes, which are coded from the AZF region on the human male Y chromosome. Deletions in this region are associated with inability to produce sperm. Subregions within the AZF region are AZFa (sometimes AZF1), AZFb and AZFc (together referred to as AZF2). AZF microdeletions are one of the major causes of male infertility for azoospermia (complete absence of sperm in the ejaculate) and severe oligozoospermia (less than 5 million spermatozoa in the ejaculate) males. AZF is the term used by the HUGO Gene Nomenclature Committee. Of the 15% of couples who are affected by infertility, 50% of those cases are due to the male partner. 15-30% of male factor infertility cases can be correlated with genetic abnormalities. One of the most commonly identified genetic abnormalities in male factor infertility are microdeletions on the long arm of the Y chromosome (Yq), specifically at a region known as the azoospermic factor (AZF) region. In certain circumstances, men with AZF mutations can turn to assisted reproductive technologies (ART), such as intracytoplasmic sperm injection (ICSI), to help them overcome their suboptimal sperm quality. However, it may be more important for clinicians to screen for Yq microdeletions, due to a growing body of evidence that AZF microdeletions have the capability to be vertically transmitted to male offspring. Minor et al. demonstrated that an AZFc mutation was vertically transmitted over three generations via fathers receiving reproductive assistance through ICSI.
=== Liver === In July 2013, the US Food and Drug Administration (FDA) issued a warning that taking ketoconazole by mouth can cause severe liver injuries and adrenal gland problems: adrenal insufficiency and worsening of other diseases related to the gland conditions. It recommends oral tablets should not be a first-line treatment for any fungal infection. It should be used for the treatment of certain fungal infections, known as endemic mycoses, only when alternative antifungal therapies are not available or not tolerated. As contraindication it should not be used in people with acute or chronic liver disease.
== Preperitoneal space == Anteriorly, it forms the thin and fibrous preperitoneal fascia that is interposed between the transversalis fascia, and the parietal peritoneum. The preperitoneal fascia contains a variable amount of fat, loose connective tissue, and membranous tissue. It is provided with its own blood supply. The membranous component lies just deep to the transversalis fascia and has been construed as a second layer of the transversalis fascia by some authors.
Sources: en.wikipedia.org
It acts as an agonist at both the GIP and GLP-1 receptors, two related class B G protein-coupled receptors. This dual activity distinguishes it from single-receptor GLP-1 agonists. The clinical consequences of engaging both receptors are still being characterized.
It is given by subcutaneous injection, generally on a weekly schedule. Dosing usually begins low and increases in steps to limit gastrointestinal side effects. Formulated product is supplied as a ready-to-use pen or vial in most markets.
No. Receptor engagement is documented, but how central appetite circuits, gut signals, and insulinotropic effects combine is incompletely resolved. Investigators continue to separate GIP-driven from GLP-1-driven contributions in animal and human models.
It separates molecules by hydrophobicity, which is effective for distinguishing an intact peptide from truncated or chemically modified forms. A C18 column with an acidic water-organic mobile phase is a standard configuration.